Ezra M Friedberg insider trades: Pelthos Therapeutics (PTHS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ezra reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | PTHS | ↓ Sell | 558 | $20.72 | $12K | Direct | Oct 6, 2026 (4d) |
| Jul 2, 2026 | PTHS | ↓ Sell | 558 | $26.09 | $15K | Direct | Jul 7, 2026 (5d) |
| Jun 15, 2026 | PTHS | ↓ Sell | 283 | $27.29 | $8K | Direct | Jun 17, 2026 (2d) |
| Apr 2, 2026 | PTHS | ↓ Sell | 558 | $20.92 | $12K | Direct | Apr 6, 2026 (4d) |
| Nov 25, 2025 | PTHS | ↓ Sell | 10,000 | $28.03 | $280K | By Balmoral Financial Group LLC | Nov 26, 2025 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PTHS insiders
Open-market trades in the last 12 months
About Ezra M Friedberg's insider trades
Ezra M Friedberg is a director at Pelthos Therapeutics (PTHS). Since Nov 25, 2025, Ezra has reported no open-market purchases and 5 sales worth $326K on SEC Form 4. In the last 12 months: 5 sales ($326K).
Their filings also include grants and awards (5 filings), conversions (2 filings), shares withheld for taxes (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PTHS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.